CN Stock MarketDetailed Quotes

688581 Hangzhou AGS Medtech

Watchlist
  • 48.93
  • -0.45-0.91%
Market Closed Jun 28 15:00 CST
3.96BMarket Cap16.78P/E (TTM)

About Hangzhou AGS Medtech Company

The company was founded in 2010 and has been committed to the design and development of products and surgical solutions in the field of minimally invasive interventional diagnosis and treatment. It is a national high-tech enterprise integrating R&D, production, sales and service. Adhering to the core values of “creating, persevering, and sharing”, the company provides patients and clinicians with safer and more efficient minimally invasive endoscopic diagnosis and treatment devices to help patients reduce pain and reduce medical costs. The company is committed to building a happy home that “makes employees happy, customers satisfied, and shareholders feel at ease”. It is an excellent enterprise that is respected by employees, competitors, and society. The company is engaged in R&D, production and sales of minimally invasive endoscopic diagnosis and treatment devices. The company's main products include GI, EMR/ESD (single and bipolar), ERCP, and diagnostic instruments. Company honors: “Zhejiang Science and Technology Little Giant”, “Hangzhou Headquarters Enterprise”, Zhejiang Intellectual Property Patent Demonstration Enterprise, etc.

Company Profile

Short Name-A安杰思医学
Company NameHangzhou AGS MedTech Co.,Ltd
Listing DateMay 19, 2023
Issue Price125.80
Shares Offered14.47M share(s)
FoundedDec 6, 2010
Chairmancheng zhang
Legal Representativecheng zhang
General Managercheng zhang
Secretaryqinhua zhang
Employees592
ProvinceZhe Jiang Sheng
Phone0571-88775216
Office AddressBuilding 5 and 6, No. 597, Kangxin Road, Yuhang District, Hangzhou, Zhejiang
Zip Code311106
Registered AddressNo. 389, Xingzhong Road, Linping District, Hangzhou, Zhejiang
EmailIR@bioags.com
Business License913301105660667546
BusinessThe company is engaged in R&D, production and sales of minimally invasive endoscopic diagnosis and treatment devices. The main products are used in the field of digestive endoscopic diagnosis and treatment. According to treatment purposes, they are divided into hemostasis, EMR/ESD, biopsy, ERCP, and diagnostic and treatment instruments.

Company Executives

  • Name
  • Position
  • Salary
  • cheng zhang
  • Chairman,directors,general manager
  • 3.30M
  • yueyuan sheng
  • directors
  • 782.71K
  • chunqi han
  • directors,Deputy General Manager,Core technical personnel
  • 1.29M
  • jianhai wu
  • Independent directors
  • 70.02K
  • lian xia
  • Independent directors
  • 70.02K
  • qinhua zhang
  • Board Secretary
  • 560.85K
  • xinyu du
  • Securities affairs representative
  • --
  • baiming shi
  • Chairman of the Supervisory Board,Core technical personnel,Employee supervisors
  • 854.60K
  • jinfeng li
  • auditors
  • 80.00K
  • weijuan shen
  • auditors
  • --
  • juncan chen
  • Chief Financial Officer
  • 1.01M
  • peng li
  • Core technical personnel
  • 462.46K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg